Empirical Finance’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$958K Sell
13,462
-2
-0% -$158 0.05% 308
2025
Q4
$1.1M Sell
13,464
-555
-4% -$43.2K 0.05% 273
2025
Q3
$1.05M Buy
14,019
+157
+1% +$11.7K 0.05% 298
2025
Q2
$1.03M Buy
13,862
+111
+0.8% +$7.73K 0.05% 290
2025
Q1
$1.11M Buy
13,751
+378
+3% +$32.5K 0.07% 257
2024
Q4
$1.05M Sell
13,373
-107
-0.8% -$9.1K 0.06% 264
2024
Q3
$1.27M Buy
13,480
+385
+3% +$32.3K 0.07% 236
2024
Q2
$1.02M Sell
13,095
-523
-4% -$42.7K 0.06% 260
2024
Q1
$1.24M Buy
13,618
+497
+4% +$41.4K 0.08% 240
2023
Q4
$1.01M Buy
13,121
+191
+1% +$13.4K 0.07% 258
2023
Q3
$880K Buy
12,930
+1,735
+15% +$126K 0.06% 262
2023
Q2
$909K Buy
11,195
+1,272
+13% +$102K 0.07% 253
2023
Q1
$814K Buy
+9,923
New +$708K 0.08% 255

Other funds holding GEHC

Empirical Finance's GEHC Position: Q1 2026 in Review

Empirical Finance reduced its GE HealthCare (GEHC) stake by 0.01% in Q1 2026, selling an estimated $158 and leaving 13,462 shares worth $958K. The position accounts for 0.05% of the portfolio, ranked #308.

Empirical Finance first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.27M in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Empirical Finance held 13,462 shares of GE HealthCare worth $958K as of Q1 2026.
  • Empirical Finance sold 2 GE HealthCare shares in Q1 2026, an estimated $158.
  • GE HealthCare made up 0.05% of Empirical Finance's portfolio in Q1 2026, its #308 holding.
  • Empirical Finance first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Empirical Finance's GE HealthCare position peaked at $1.27M in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Empirical Finance's 13F filing for Q1 2026, filed 14 May 2026.